Incyte hands CEO Hoppenot a 36% pay hike despite R&D setbacks by Arlene Weintraub Tuesday, March 20, 2018 Incyte CEO Hervé Hoppenot scored a big pay raise in 2017, even after the FDA rebuffed the highly anticipated RA drug it's developing with Eli Lilly.
Drama and diagnosis on soap opera set puts Incyte in hot seat by Beth Snyder Bulik Monday, May 22, 2017 Soap operas often include medical mysteries and miracles, but some doctors are concerned about Incyte's connection to General Hospital's latest drama.
